LH
GSK icon

Lebenthal Holdings’s GSK GSK Stock Holding History

Lebenthal Holdings’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-4,680
Closed -$237K – 368
2016
Q1 		$237K Sell
4,680
-178
-4% -$8.87K 0.04% 312
2015
Q4 		$245K Sell
4,858
-100
-2% -$5.1K 0.06% 256
2015
Q3 		$238K Sell
4,958
-382
-7% -$19.9K 0.05% 278
2015
Q2 		$278K Sell
5,340
-6,084
-53% -$343K 0.06% 267
2015
Q1 		$659K Buy
11,424
+2,169
+23% +$124K 0.15% 189
2014
Q4 		$494K Buy
+9,255
New +$518K 0.22% 122

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Lebenthal Holdings's GSK Position: Q2 2016 in Review

Lebenthal Holdings sold out of GSK (GSK) in Q2 2016, closing a stake of 4,680 shares — an estimated $237K sold.

Lebenthal Holdings first reported a position in GSK in Q4 2014 and held it in 6 quarters. The position peaked at $659K in Q1 2015. 741 funds tracked by Wall St. Rank hold GSK as of Q2 2016.

  • Lebenthal Holdings reported no remaining GSK position as of Q2 2016 after selling out during the quarter.
  • Lebenthal Holdings sold 4,680 GSK shares in Q2 2016, an estimated $237K.
  • Lebenthal Holdings first reported a position in GSK in Q4 2014 and held it in 6 quarters.
  • Lebenthal Holdings's GSK position peaked at $659K in Q1 2015.
  • 741 funds tracked by Wall St. Rank held GSK as of Q2 2016.

Based on Lebenthal Holdings's 13F filing for Q2 2016, filed 19 Aug 2016.